Peer-reviewed veterinary case report
574-day survival time in canine patient with lymphoblastic lymphoma and treated with chemotherapy protocols – case report
- Journal:
- Clínica Veterinária
- Year:
- 2015
- Authors:
- Vilma Ferreira de Oliveira et al.
- Species:
- dog
Plain-English summary
Lymphoma is a common type of cancer in dogs, especially in older ones, and it involves the rapid growth of abnormal cells that affect blood cell production. In this case, a four-year-old male Labrador was diagnosed with lymphoblastic lymphoma and underwent four different chemotherapy treatments. Despite experiencing three relapses during his treatment, he managed to live for 574 days after his diagnosis. Unfortunately, he was eventually euthanized after the fourth relapse.
Abstract
Domestic canines are very susceptible to developing cancer, and lymphoma is the most common type of canine neoplasia. Lymphomas are characterized by the fast proliferation of abnormal lymphoid cells, which interferes directly in hematopoietic dynamics. Lymphomas have multifactorial etiology and there is no confirmation of sexual or specific racial predilection, although it is suggested that older animals seem to be more susceptible. The prognosis is unfavorable and survival rates tend to be low. This article relates the case of a lymphoblastic lymphoma in a four-year-old male Labrador that survived for 574 days while treated with four chemotherapy protocols. The animal suffered three relapses, been subjected to euthanasia after the fourth.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://www.semanticscholar.org/paper/998b847a033802fb68942139df8a8ec6b0d55fc4